相关实验视频

Updated: Jul 1, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

新型自动自调皮下胰岛素算法改善了住院患者的血糖控制和医生的效率

Paras B Mehta¹, Michael A Kohn², Esther Rov-Ikpah³

¹Division of Endocrinology and Metabolism, University of California, San Francisco, CA, USA.

Journal of diabetes science and technology

|March 8, 2024

概括

一种新的自动化皮下胰岛素算法 (SQIA) 降低了住院患者的严重高血糖和低血糖. 这种先进的血糖控制也显著提高了医生的效率,最大限度地减少了胰岛素顺序调整.

科学领域:

临床医学临床医学
医疗技术医疗技术医学技术
内分泌学在内分泌学.

背景情况:

高血糖在住院患者中很普遍,对死亡率和医院费用等结果产生负面影响.
由于营养变化,急性疾病和劳动密集型监测等因素,住院血糖控制很困难.
在医院有效管理血糖水平仍然是一个重大的临床挑战.

研究的目的:

为了比较新型自动化皮下胰岛素算法 (SQIA) 与传统的医生驱动胰岛素剂量的疗效和安全性.
评估SQIA对住院患者的血糖控制和医生效率的影响.
通过自动化胰岛素管理来评估严重高血糖和低血糖事件的减少.

主要方法:

从2020年9月到2021年9月,在UCSF医院进行了回顾性横截面分析.
在接受SQIA和常规胰岛素剂量治疗的患者之间,对照治疗点的葡萄糖测量结果进行了比较.
医生的效率是通过跟踪注册或修改的胰岛素订单数量来评估的.

主要成果:

在SQIA组中,葡萄糖在范围中占比较高的趋势 (71.0%对69.0%).
SQIA显著减少了严重的高血糖 (5.8%与7.2%相比),低血糖 (0.8%与1.2%相比) 和严重的低血糖 (0.3%与0.5%相比).
与传统剂量相比,医生订单修改在SQIA下降了12倍以上.

结论:

自动化皮下胰岛素算法 (SQIA) 在住院患者中有效降低了严重的高血糖和低血糖.
通过最大限度地减少危险的葡萄糖波动,SQIA证明了患者安全的提高.
该算法显著提高了医生的效率,减少了胰岛素订单管理的负担.

关键词:

血中的葡萄糖血中的葡萄糖住院患者糖尿病管理没有Nil每一个OS每一个OS.医生的效率效率是医生的效率.自调整性胰岛素的管理自调整性胰岛素的管理总体亲肠道营养输管养输管养输管养

更多相关视频

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

相关概念视频

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...

SBAR II: Application of SBAR

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...